Publicacións nas que colabora con Jordi Carratalà Fernández (19)

2023

  1. Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial

    Nature Medicine, Vol. 29, Núm. 10, pp. 2518-2525

  2. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

    International Journal of Infectious Diseases, Vol. 137, pp. 134-143

2022

  1. Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria

    Open Forum Infectious Diseases, Vol. 9, Núm. 9

2021

  1. Clinical Features and Outcomes of Streptococcus anginosus Group Infective Endocarditis: A Multicenter Matched Cohort Study

    Open Forum Infectious Diseases, Vol. 8, Núm. 6

  2. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

    The Lancet Infectious Diseases, Vol. 21, Núm. 6, pp. 783-792

  3. Mural Endocarditis: The GAMES Registry Series and Review of the Literature

    Infectious Diseases and Therapy, Vol. 10, Núm. 4, pp. 2749-2764

  4. Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

    Clinical Microbiology and Infection, Vol. 27, Núm. 2, pp. 244-252

2020

  1. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain

    Clinical Microbiology and Infection, Vol. 26, Núm. 11, pp. 1525-1536

2018

  1. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

    American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522

2016

  1. Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma

    Hepatology, Vol. 63, Núm. 2, pp. 488-498

  2. Liver Retransplantation in Patients with HIV-1 Infection: An International Multicenter Cohort Study

    American Journal of Transplantation, Vol. 16, Núm. 2, pp. 679-687

2014

  1. Prevention strategies for cytomegalovirus disease and long-term outcomes in the high-risk transplant patient (D+/R-): Experience from the RESITRA-REIPI cohort

    Transplant Infectious Disease, Vol. 16, Núm. 3, pp. 387-396

2012

  1. Bacterial urinary tract infection after solid organ transplantation in the RESITRA cohort

    Transplant Infectious Disease, Vol. 14, Núm. 6, pp. 595-603

  2. Outcome of Clostridium difficile-associated disease in solid organ transplant recipients: A prospective and multicentre cohort study

    Transplant International, Vol. 25, Núm. 12, pp. 1275-1281

2010

  1. Immunosuppressive therapy and infection after kidney transplantation

    Transplant Infectious Disease, Vol. 12, Núm. 5, pp. 397-405

2009

  1. Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the resitra (spanish network of infection in transplantation) cohort

    Clinical Infectious Diseases, Vol. 48, Núm. 12, pp. 1657-1665

2008

  1. Donor infection and transmission to the recipient of a solid allograft

    American Journal of Transplantation, Vol. 8, Núm. 11, pp. 2420-2425

  2. Incisional surgical infection in heart transplantation

    Transplant Infectious Disease, Vol. 10, Núm. 4, pp. 298-302

  3. Valganciclovir as treatment for cytomegalovirus disease in solid organ transplant recipients

    Clinical Infectious Diseases, Vol. 46, Núm. 1, pp. 20-27